Filter

221 - 230 of 239 Results

  • Global Health Diplomacy: Advancing Foreign Policy and Global Health Interests

    Issue Brief

    This article examines the growing attention to global health diplomacy and its future outlook as donor nations continue to face tight budgetary conditions. Authored by Joshua Michaud and Jennifer Kates of the Kaiser Family Foundation, the article was published in the inaugural issue of the Global Health: Science and Practice journal in March 2013. Article

  • What’s Next for U.S. Global Health Diplomacy? A Town Hall Forum with Ambassador Eric Goosby

    Event Date:
    Event

    At 9:30 a.m. ET on Thursday, Feb. 28, the Kaiser Family Foundation will host a town hall-style forum with Ambassador Eric Goosby, the newly named head of the State Department's new Office of Global Health Diplomacy as well as U.S. Global AIDS Coordinator, to explore the goals and objectives of the new office. The office is intended to guide diplomatic efforts to advance the United States' global health mission to improve and save lives and…

  • The U.S. Department of Defense & Global Health

    Report

    This report provides the first comprehensive look at the role of the Department of Defense (DoD) in global health, examining its organizational structure, activities, strategy, policy, and budget for activities related to global health.

  • The Global Fund Reorganization: What are the Implications?

    Event Date:
    Event

    On Wednesday, June 13, at 12:00 p.m. ET (noon), the Foundation held a live, interactive webcast to examine recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria and the implications for U.S. global health policy. A panel of experts discussed the Global Fund's recent funding challenges and reorganization, how the U.S. and other donor nations are responding to these changes, and the future outlook for the Fund’s efforts to address HIV, TB, and…

  • The President’s Budget Request: What Does It Mean For U.S. Global Health Efforts?

    Event Date:
    Event

    On Tuesday, February 21, the Kaiser Family Foundation held a live webcast to assess President Obama's fiscal year 2013 budget proposal and potential implications for global health. The webcast featured a panel of global health policy experts who analyzed the Administration's proposal and how it compares to current funding levels, what may happen as the budget winds its way through Congress, and the implications for the future of U.S. global health programs. Panelists: Ambassador Mark…

  • Exploring HHS’ Role in Global Health & New Global Health Strategy

    Event Date:
    Event

    This Kaiser Family Foundation and U.S. Department of Health and Human Services briefing explores the Department's role in global health and its Global Health Strategy. The event features opening remarks by HHS Secretary Kathleen Sebelius.

  • Inside Deficit Reduction: What Now?

    Event Date:
    Event

    The Budget Control Act of 2011 tasked members of a "Super Committee" to find at least $1.2 trillion in deficit reduction over the next decade. Members did not reach an agreement by the November 23 deadline and as a result automatic spending cuts to defense and entitlement programs are set to kick in beginning in January 2013. Panelists at this briefing discussed the impact the sequester will have on the health care sector and how…

  • Health and Development Outcomes of the G-20 Summit

    Event Date:
    Event

    This November 9, 2011 webcast features an expert panel discussing the outcomes of the Cannes G-20 Summit and implications for global health. It is part of the Foundation's "U.S. Global Health Policy: In Focus" series.

  • Pharmaceutical Policy and Pricing: Are Other Countries Getting Greater Value?

    Event Date:
    Event

    Spending on prescription drugs in the U.S. rose at a faster clip in 2009 than spending for hospital and physician care, a trend that is expected to continue through 2020. The desire to get a handle on drug spending is a focus not only in the U.S. but in other countries as well. What are some strategies used in our country and in the UK, Germany and France to control pharmaceutical spending? How well are…